πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 175 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8198242

Variants of C-type natriuretic peptide

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8128925

Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses the

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8088760

Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP)

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8067416

Methods and compositions for the treatment of metabolic disorders

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8012976

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8003126

Stable tablet formulation

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7981864

Methods and compositions for targeting proteins across the blood brain barrier

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7947681

Methods of administering tetrahydrobiopterin, associated compositions, and methods of meas

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7947737

Method of treating hypertension and reducing serum lipase activity

Aker Biomarine AS Β· Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790433

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7776353

Conjugated linoleic acid compositions

Aker Biomarine AS Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7732599

Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7722865

Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses the

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7612073

Methods of administering tetrahydrobiopterin, associated compositions, and methods of meas

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7601717

Pterin analogs

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7566714

Methods and compositions for the treatment of metabolic disorders

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7566462

Stable tablet formulation

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7560263

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7553653

Variants and chemically-modified variants of phenylalanine ammonia-lyase

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7537923

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7534595

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7531341

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7514096

Triacylglycerols of enriched CLA content

Aker Biomarine AS Β· Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7452548

Conjugated linoleic acid compositions

Aker Biomarine AS Β· Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted